Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
Go back to Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia| PACIRA (NASDAQ: PCRX) | Delayed: 25.91 -0.44 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.35 | 52 Week High | $80.25 | |||
| Open | $25.98 | 52 Week Low | $30.25 | |||
| Day High | $26.41 | P/E | N/A | |||
| Day Low | $25.68 | EPS | $-2.08 | |||
| Volume | 100,628 | |||||
| PACIRA (NASDAQ: PCRX) | Delayed: 25.91 -0.44 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.35 | 52 Week High | $80.25 | |||
| Open | $25.98 | 52 Week Low | $30.25 | |||
| Day High | $26.41 | P/E | N/A | |||
| Day Low | $25.68 | EPS | $-2.08 | |||
| Volume | 100,628 | |||||

